$0.1000
At close: Aug 26, 4:00 PM EDT
Comments
Loading...
StemGen Analyst Ratings and Price Targets | OTC:SGNI | Benzinga
StemGen Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for StemGen Corp from these most-recent analyst ratings.
Analyst Ratings for StemGen
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for StemGen (SGNI) stock?
There is no price target for StemGen
What is the most recent analyst rating for StemGen (SGNI)?
There is no analyst for StemGen
When was the last upgrade for StemGen (SGNI)?
There is no last upgrade for StemGen
When was the last downgrade for StemGen (SGNI)?
There is no last downgrade for StemGen.
When is the next analyst rating going to be posted or updated for StemGen (SGNI)?
There is no next analyst rating for StemGen.
Is the Analyst Rating StemGen (SGNI) correct?
There is no next analyst rating for StemGen.
Browse analyst ratings and price targets on all stocks.
